Table of contents

Extended reports

• Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium (17 December, 2004)

  C Weidler, C Holzer, M Harbuz, R Hofbauer, P Angele, J Schölmerich, R H Straub
• Up regulated expression of fractalkine/CX₃CL1 and CX₃CR1 in patients with systemic sclerosis

  (17 December, 2004)

  M Hasegawa, S Sato, T Echigo, Y Hamaguchi, M Yasui, K Takehara
• Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement (18 June, 2004)

  F Tubach, P Ravaud, G Baron, B Falissard, I Logeart, N Bellamy, C Bombardier, D Felson, M Hochberg, D van der Heijde, M Dougados
• Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state (6 May, 2004)

  F Tubach, P Ravaud, G Baron, B Falissard, I Logeart, N Bellamy, C Bombardier, D Felson, M Hochberg, D van der Heijde, M Dougados
• A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up (6 May, 2004)

  S M M Verstappen, G A van Albada-Kuipers, J W J Bijlsma, A A M Blaauw, Y Schenk, H C M Haanen, J W G Jacobs
• When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? (22 July, 2004)

  M Dougados, P Emery, E M Lemmel, C A F Zerbini, S Brin, P van Riel
• Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis (29 July, 2004)

  F C Breedveld, C Han, M Bala, D van der Heijde, D Baker, A F Kavanaugh, R N Maini, P E Lipsky
• Capability for daily activities in old people with rheumatoid arthritis: a population based study (17 December, 2004)

  M Kauppi, S Hartikainen, H Kautiainen, K Laiho, R Sulkava
• Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis (6 May, 2004)

  A Häkkinen, H Kautiainen, P Hannonen, J Ylinen, M Arkela-Kautiainen, T Sokka
• A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (8 July, 2004)

  J van Holten, K Pavelka, J Vencovsky, H Stahl, B Rozman, M Genovese, A J Kivitz, J Alvaro, G Nuki, D E Furst, G Herrero-Beaumont, I B McInnes, P Musikic, P P Tak
• First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence (17 December, 2004)

  L Denoeud, B Mazières, C Payen-Champenois, P Ravaud
• Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale (17 December, 2004)

  F Tubach, G Baron, B Falissard, I Logeart, M Dougados, N Bellamy, P Ravaud
• Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index (1 July, 2004)

  H A Bischoff-Ferrari, M Vondechend, N Bellamy, R Theiler
• Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout (28 April, 2004)

  F Cardona, F J Tinahones, E Collantes, A Escudero, E García-Fuentes, F J Soriguer
• Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis

  (17 December, 2004)

  A R Shikhman, D Amiel, D D’Lima, S-B Hwang, C Hu, A Xu, S Hashimoto, K Kobayashi, T Sasho, M K Lotz
• Defining hip pain for population studies (17 December, 2004)

  F Birrell, M Lunt, G J Macfarlane, A J Silman
• Prevalence and determinants of one month hand pain and hand related disability in the elderly (Rotterdam study) (17 December, 2004)

  S Dahaghin, S M A Bierma-Zeinstra, M Reijman, H A P Pols, J M W Hazes, B W Koes
• Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis (17 December, 2004)

  A D Wagner, J Andresen, E Raum, J Lotz, H Zeidler, J G Kuipers, M C Jendro
• Prevalence and predictors of fragility fractures in systemic lupus erythematosus (17 December, 2004)

  C-S Yee, N Crabtree, J Skan, N Amft, S Bowman, D Situnayake, C Gordon
• Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome (1 July, 2004)

  J-E Gottenberg, S Mignot, P Nicaise-Rolland, J Cohen-Solal, F Aucouturier, J Goetz, C Labarre, O Meyer, J Sibilia, X Mariette
• Incidence and prevalence of complaints of the neck and upper extremity in general practice (17 December, 2004)

  S D M Bot, J M van der Waal, C B Terwee, D A W M van der Windt, F G Schellevis, L M Bouter, J Dekker